Bazı Oksim Bileşiklerinin Bağlanma Özelliklerinin Moleküler Kenetlenme Yöntemiyle İncelenmesi
Abstract
Keywords
Supporting Institution
Project Number
Thanks
References
- [1] Snodin, D. J. 2002. An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology. Toxicology Letters, 127(1-3), 161-168.
- [2] Kraljevic, S., Stambrook, P. J., Pavelic, K. 2004. Accelerating drug discovery. EMBO Reports, 5(9), 837-842.
- [3] Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., Khan, S., Kamal, M. A., Provazník, I., Choi, I. 2016. Computer aided drug design: success and limitations. Current Pharmaceutical Design, 22(5), 572-581.
- [4] Baig, M. H., Ahmad, K., Rabbani, G., Danishuddin, M., Choi, I. 2018. Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders. Current Neuropharmacology, 16(6), 740-748.
- [5] Scotti, L., Tullius Scotti, M. 2015. Computer aided drug design studies in the discovery of secondary metabolites targeted against age-related neurodegenerative diseases. Current Topics in Medicinal Chemistry, 15(21), 2239-2252.
- [6] Rohs, R., Bloch, I., Sklenar, H., Shakked, Z. 2005. Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations. Nucleic Acids Research, 33(22), 7048-7057.
- [7] Guedes, I. A., de Magalhães, C. S., Dardenne, L. E. 2014. Receptor–ligand molecular docking. Biophysical Reviews, 6(1), 75-87.
- [8] Agarwal, S., Chadha, D., Mehrotra, R. 2015. Molecular modeling and spectroscopic studies of semustine binding with DNA and its comparison with lomustine–DNA adduct formation. Journal of Biomolecular Structure and Dynamics, 33(8), 1653-1668.
Details
Primary Language
Turkish
Subjects
Engineering
Journal Section
Research Article
Publication Date
August 26, 2020
Submission Date
December 25, 2019
Acceptance Date
May 13, 2020
Published in Issue
Year 2020 Volume: 24 Number: 2